Evidence map›Paper›PMID 30584303›Full record

ReviewInternational journal of nanomedicine2018

Nanotechnology-enabled materials for hemostatic and anti-infection treatments in orthopedic surgery.

Haolin Sun, Lu Lv, Yanjie Bai, Huilin Yang, Huan Zhou, Chunde Li, Lei Yang

Open access · goldAbstract readReview
In one paragraph

Review in International journal of nanomedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Safety Landscape of Therapeutic Nanozymes and Future Research Directions.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  6. Review
  7. Article
  8. Giant atypical lipomatous tumors of the thigh: a case series.Acta bio-medica : Atenei Parmensis · 2023
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Nanotechnology-based drug delivery systems in orthopedics.Joint diseases and related surgery · 2021
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Haolin SunDepartment of Orthopaedics, Peking University First Hospital, Beijing 100034, China, chundeli@yeah.cn.
Lu LvOrthopaedic Institute and Department of Orthopaedics, Soochow University, Suzhou 215006, China, leiy@suda.edu.cn.
Yanjie BaiSchool of Public Health, Medical College, Soochow University, Suzhou 215000, China.
Huilin YangInternational Research Center for Translational Orthopaedics (IRCTO), Soochow University, Suzhou 215006, China, leiy@suda.edu.cn.
Huan ZhouInternational Research Center for Translational Orthopaedics (IRCTO), Soochow University, Suzhou 215006, China, leiy@suda.edu.cn.
Chunde LiDepartment of Orthopaedics, Peking University First Hospital, Beijing 100034, China, chundeli@yeah.cn.
Lei YangInternational Research Center for Translational Orthopaedics (IRCTO), Soochow University, Suzhou 215006, China, leiy@suda.edu.cn.
Soochow University · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The hemostatic and anti-infection treatments in the field of orthopedics are always the pivotal yet challenging topics. In the first part of this review, synthesized or naturally derived nanoscale agents and materials for hemostatic treatment in orthopedic surgery are introduced. The hemostatic mechanisms and the safety concerns of these nanotechnology-enabled materials are discussed. Beside the materials to meet hemostatic needs in orthopedic surgery, the need for antimicrobial or anti-infection strategy in orthopedic surgery also becomes urgent. Nanosilver and its derivatives have the most consistent anti-infective effect and thus high translational potential for clinical applications. In the second part, the factors affecting the antimicrobial effect of nanosilver and its application status are summarized. Finally, the status and translational potential of various nanotechnology-enabled materials and agents for hemostatic and anti-infective treatments in orthopedic surgery are discussed.

Indexed as

Orthopedic ProceduresAnimalsAnti-Infective AgentsBiocompatible MaterialsHemostaticsHumansNanotechnologyTranslational Research, BiomedicalAnti-Infective AgentsBiocompatible MaterialsHemostaticsantimicrobialhemostaticnanotechnologyorthopedic surgery

Identifiers

PMID30584303
PMCPMC6289228
OpenAlexW2902616562

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.